Harvard Bioscience, Inc. announced the resignation of Jennifer Cote, the company’s Chief Financial Officer and Treasurer, effective upon the filing of the company’s Quarterly Report on Form 10-Q, expected on or before May 12, 2025. Ms. Cote was instrumental in leading the finance team and sponsoring the recent ERP system consolidation project.
The company has appointed Mark Frost as its Interim Chief Financial Officer and Treasurer, effective upon Ms. Cote’s resignation. Mr. Frost brings over 30 years of financial and executive-level management experience from both private and public companies, having served as a consultant to Harvard Bioscience since January 2025.
Mr. Frost's prior roles include Chief Financial Officer positions at Fathom, Argon Medical Devices, Analogic, AngioDynamics, and AMRI, and he began his career with General Electric. Jim Green, Chairman and CEO, expressed confidence in Mr. Frost’s financial and business acumen to lead the finance team in a challenging market environment.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.